Listed

Adaptimmune Therapeutics PLC

ADAPYOTCCIK 1621227HealthcareFiscal year ends Dec 31

Reports and events: 279 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Adaptimmune Therapeutics PLC, Reports and events
FiledFormWhat it isAccession number
2019-05-0614:57 ET10-QQuarterly reportPeriod 2019-03-310001558370-19-004059
2019-05-0608:11 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-19-026974
2019-05-0607:38 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-19-026967
2019-05-0607:08 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-19-026958
2019-05-0216:56 ET8-K5.07 Shareholder vote results0001104659-19-026508
2019-05-0207:10 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-19-026207
2019-04-0208:10 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-19-019174
2019-03-1517:01 ETDEF 14AProxy statementPeriod 2019-05-020001047469-19-001324
2019-02-2717:22 ET10-KAnnual reportPeriod 2018-12-310001558370-19-001209
2019-02-2717:16 ET8-K/A2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-19-011164
2019-02-2707:43 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-19-010927
2019-01-0707:40 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-19-000986
2018-12-1208:39 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-18-072463
2018-11-0610:58 ET10-QQuarterly reportPeriod 2018-09-300001104659-18-066229
2018-11-0607:36 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-18-066178
2018-10-2208:38 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-18-063179
2018-10-1014:37 ETSC 13D/AOwnership report, active investor, amended0000947871-18-000810
2018-09-1715:45 ETSC 13DOwnership report, active investor0001072613-18-000476
2018-09-0713:27 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-18-055759
2018-09-0507:50 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-18-055198
2018-08-1507:39 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-18-052132
2018-08-0212:13 ET10-QQuarterly reportPeriod 2018-06-300001104659-18-049058
2018-08-0207:41 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-18-048987
2018-07-2407:36 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-18-046630
2018-07-1817:01 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-18-045789
2018-07-0617:00 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-18-044174
2018-06-2017:00 ET8-K5.07 Shareholder vote results0001104659-18-041291
2018-06-0407:38 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-18-037806
2018-05-0912:32 ET10-QQuarterly reportPeriod 2018-03-310001104659-18-031628
2018-05-0907:39 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-18-031514
2018-04-2717:00 ETDEF 14AProxy statementPeriod 2018-06-200001047469-18-003307
2018-04-1217:02 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-18-023736
2018-03-2917:24 ETSC 13D/AOwnership report, active investor, amended0000947871-18-000304
2018-03-1511:29 ET10-KAnnual reportPeriod 2017-12-310001104659-18-017694
2018-03-1507:42 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-18-017637
2018-01-2614:36 ETSC 13D/AOwnership report, active investor, amended0000947871-18-000062
2018-01-0808:12 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-18-001125
2018-01-0808:10 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-18-001123
2017-11-1316:45 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-17-067996
2017-11-0210:46 ET10-QQuarterly reportPeriod 2017-09-300001104659-17-065442
2017-11-0208:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-17-065389
2017-09-0707:40 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-17-055957
2017-08-0311:53 ET10-QQuarterly reportPeriod 2017-06-300001104659-17-049218
2017-08-0307:38 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-17-049119
2017-07-2416:45 ET8-K5.05 Item not in the standard list; 9.01 Financial statements and exhibits0001104659-17-046539
2017-07-0316:45 ET8-K8.01 Other events0001104659-17-043258
2017-06-2116:45 ET8-K5.07 Shareholder vote results0001104659-17-040686
2017-06-0608:19 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-17-037598
2017-06-0510:28 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-17-037379
2017-05-2615:52 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-17-035681

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.